12:00 AM
Nov 10, 2008
 |  BC Week In Review  |  Clinical News  |  Clinical Status

VaxiSome: Phase I/IIa started

NasVax began a double-blind, active-controlled, Israeli Phase l/lla trial of single intramuscular doses of VaxiSome in 80 healthy elderly...

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >